自发性细菌性腹膜炎诊断和治疗现状  

Current status of the diagnose and treatment of spontaneous bacterial peritonitis

作　　者：黎倍伶 钟国涛 陈金军[1] LI Beiling;ZHONG Guotao;CHEN Jinjun(Liver Disease Center, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China)

机构地区：[1]南方医科大学南方医院肝病中心

出　　处：《临床肝胆病杂志》2019年第9期2079-2081,共3页Journal of Clinical Hepatology

基　　金：科技部病毒性肝炎及艾滋病等传染病重大专项(2018ZX10723203);国家自然科学基金(81270533,81470038);国家重点研发计划(2017YFC0908100)

摘　　要：感染是肝硬化患者的常见并发症,而自发性细菌性腹膜炎(SBP)为最常见的感染类型。总结基于腹水多核细胞数大于250/μl的SBP诊断标准形成过程、腹水细胞计数的局限性和SBP的治疗现状。提示目前SBP的诊断需要新的灵敏检测标志物,用于指导临床经验性抗菌治疗,从而优化SBP患者管理。Infection is a common complication in patients with liver cirrhosis,and spontaneous bacterial peritonitis( SBP) is the most common type of infection.This article summarizes the formation process of the diagnostic criteria of SBP based on a number of multinuclear cells of > 250 cells/μl in ascites,limitations of ascites cell counting,and the current status of the treatment of SBP.It is pointed out that novel biomarkers with high sensitivity are needed for the diagnosis of SBP diagnose,in order to guide empirical antimicrobial treatment and optimize the management of patients with SBP in clinical practice.

关 键 词：腹膜炎 肝硬化 诊断 

分 类 号：R575.2[医药卫生—消化系统]